RUDN Journal of Ecology and Life Safety (Dec 2015)
DYNAMICS ANTIAGGREGATORY ACTIVITY OF THE VASCULAR WALL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREES IN THE METABOLIC SYNDROME RECEIVING LISINOPRIL IN THE TREATMENT OF COMPLEX
Abstract
Treatment of socially significant diseases is an important task, acutely facing medicine today. In the work evaluated the possibility of a complex correction, including lisinopril, pioglitazone and non-pharmacological treatments, in terms of its impact on the antiaggregatory activity of the vascular wall in patients with arterial hypertension of 1-2 degrees in the metabolic syndrome. Against the backdrop of the surveyed contingent of this complex treatment after 4 months the full normalization of antiaggregatory activity of the vascular wall. The results are stored within a year of treatment, even if lax adherence to non-pharmacological component correction after 16 weeks of therapy.